ROSEN, LEADING INVESTOR COUNSEL, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TMCI

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of Treace Medical Concepts, Inc. securities for the period between May 8, 2023, and May 7, 2024, due to alleged misleading statements and failure to disclose critical information regarding the company's primary product and its market performance [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that Treace Medical's management made false and/or misleading statements about the demand for its Lapiplasty 3D Bunion Correction System, which led to a decline in revenue and necessitated an accelerated product development plan [5]. - The lawsuit alleges that the positive statements made by Treace Medical regarding its business operations and prospects were materially misleading and lacked a reasonable basis [5]. Group 2: Participation Information - Investors who purchased Treace Medical securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested parties can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6]. Group 3: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4].